20/20 Biolabs Furnishes Investor Presentation for Sept 2 Webinar

What Happened

• 20/20 Biolabs, Inc. (ticker: AIDX) filed a Form 8-K on September 2, 2026 disclosing that it will use the materials attached as Exhibit 99.1 in an investor webinar on September 2, 2026.
• The company stated the furnishing of these materials is not a representation that it was required by Regulation FD or other securities laws, and it does not assume any obligation to update the information in the future.

Key Details

• Filing date: September 2, 2026 (Form 8-K).
• Item reported: 7.01 (Regulation FD Disclosure) — presentation materials to be used in a Sept 2, 2026 webinar.
• Exhibit included: Exhibit 99.1 — Investor Presentation, September 2026.
• Company clarified the materials are furnished (not redistributed as a new Regulation FD filing) and no update obligation is assumed.

Why It Matters

• Investors should review the attached investor presentation (Exhibit 99.1) for any company updates or information shared in the webinar, since the 8-K makes those materials publicly available.
• The company’s statement that it does not assume an obligation to update means any forward-looking or new details in the presentation may not be revised later; investors should consider the presentation as a current snapshot and check for future filings or disclosures for updates.